Sign in
Stories
Ivermectin Controversy: Trial Challenges Revealed
Share
CDC's Vaccine Cover-Up
COVID Reporting Requirements Expire
COVID Vaccines and Long COVID Link
CDC Revises COVID Guidelines
COVID-19 Booster for Chinese New Year
COVID-19's Impact on Brain Health
Overview
API
The ongoing debate surrounds the efficacy of using ivermectin to treat COVID-19, with conflicting reports on its effectiveness. Improper dosing, statistical interpretations, and biases have influenced trial outcomes.
Ask a question
How can the discrepancies in trial outcomes regarding ivermectin be reconciled to ensure accurate assessments?
In what ways could the lack of profit motive impact the future research and development of potential COVID-19 treatments?
What steps can be taken to address biases and conflicts of interest in future evaluations of ivermectin's effectiveness?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage